Pfizer, BioNTech seek USFDA nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine for ages 12 years and older as primary series or booster Ruchika Sharma25 Feb 2023 12:30 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that they have submitted a supplemental Biologics License Application (sBLA) to the U.S....
BioNTech, Fosun Pharma get full regulatory approval for COMIRNATY in individuals 12 years and older in Hong Kong Ruchika Sharma27 Dec 2022 1:30 PM ISTShanghai: BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. have announced that the Fosun Industrial Co., Limited (as a...
Pfizer eyes USD 10 billion- USD 15 billion in potential revenue from mRNA vaccines by 2030 Ruchika Sharma13 Dec 2022 12:13 PM ISTNew York: Pfizer Inc said on Monday that annual revenue from its mRNA vaccine portfolio could reach $10 billion to $15 billion by 2030, alleviating...
Pfizer, BioNTech get positive CHMP opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine booster for children 5 through 11 years of age in EU Ruchika Sharma13 Nov 2022 2:00 PM IST-New York: Pfizer Inc. and BioNTech SE have announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY...
Pfizer COVID vaccine approved for children as young as six months in Brazil Ruchika Sharma19 Sept 2022 1:30 PM ISTRio De Janeiro: Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between...
Pfizer- BioNTech get positive CHMP opinion for conversion of COMIRNATY conditional marketing nod to full marketing nod in EU Ruchika Sharma18 Sept 2022 9:00 AM ISTNew Delhi: Pfizer and BioNTech have announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
Pfizer, BioNTech Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster get CHMP nod Ruchika Sharma14 Sept 2022 11:37 AM ISTIf an authorization is granted, the Pfizer-BioNTech bivalent Omicron BA.4/BA.5 COVID-19 vaccine will be available within the coming days to all 27 EU...
Pfizer-BioNTech bivalent booster for Omicron, original COVID strain gets UK nod Ruchika Sharma5 Sept 2022 12:45 PM ISTIn each dose of the booster vaccine called "Comirnaty bivalent Original/Omicron", half of the vaccine (15 micrograms) targets the original virus...
BioNTech, Pfizer sue CureVac in US over COVID jab patent claims Rahul Verma27 July 2022 6:00 PM ISTCOVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District Court in Massachusetts,...
Pfizer, BioNTech sue CureVac in US over COVID vaccine patent claims Ruchika Sharma27 July 2022 4:44 PM ISTFrankfurt: COVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District Court in...
Pfizer, BioNTech submit variation to EMA for vaccination of children 6 months to less than 5 years with COMIRNATY Ruchika Sharma11 July 2022 4:27 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the companies have submitted a variation to the European Medicines Agency...
Pfizer-BioNTech gets USFDA nod for COVID vaccine Comirnaty for adolescents 12 through 15 years of age Ruchika Sharma9 July 2022 1:45 PM ISTCOMIRNATY (COVID-19 Vaccine, mRNA) is a vaccine approved for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute...
